Log In
BCIQ
Print this Print this
 

DS107G, oral DS107 (Oral DGLA)

  Manage Alerts
Collapse Summary General Information
Company DS Biopharma
DescriptionOral formulation of a semi-synthetic derivative of dihomo-gamma-linolenic acid, an omega-6 fatty acid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today